FDA Clears CorNeat EverPatch, World’s First Non-degradable, Synthetic Tissue Substitute for Ophthalmic Surgery

CorNeat Vision’s EverPatch Utilizes EverMatrix™, A Novel Material Technology Able to Integrate with Surrounding Tissue RA’ANANA, Israel, June 12, 2023 /PRNewswire/ — CorNeat Vision’s EverPatch, a synthetic tissue substitute, has been granted 510(k) clearance by the US Food & Drug…